Weight Loss Supplement

Hydroxycut Regular

353 adverse event reports submitted to the FDA · 2009–2014 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 353 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Emotional Distress

118

Liver Function Test Abnormal

106

Injury

Pain

Rhabdomyolysis

Anxiety

Renal Failure

Liver Injury

Hepatocellular Injury

Convulsion

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Other Serious or Important Medical Event	320
Hospitalization	92
Visited a Health Care Provider	54
Disability	15
Required Intervention	15
Life Threatening	10
Visited Emergency Room	10
Other Serious Outcome	9
Death	6

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

106

50–64

65–79

80+

Unknown

116

237 reports had age data; 116 unknown.

Gender

Female

118

Male

216

Unknown/Not Reported

Reports by Year

Annual report counts from 2009–2014. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'09

'10

'11

'12

'13

'14

Hover bars for exact counts.

Context about this data: Reports concentrated in 2010–2011, during the post-recall period following Hydroxycut's 2009 market withdrawal and reformulation.

← View all Hydroxycut products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology